Skip to content
Clinical Trials – home

BETULA VERRUCOSA POLLEN: A Comprehensive Guide for Patients

0 / 2
trials open to patients / all trials
6+
Countries

In short

This article explores recent clinical trials investigating the use of Betula Verrucosa Pollen (birch pollen) in the treatment of allergic rhinitis and rhinoconjunctivitis. These studies aim to assess the effectiveness and safety of various immunotherapy approaches using birch pollen extracts to alleviate symptoms in patients with birch pollen allergies. The trials focus on different formulations and administration methods, including subcutaneous injections and skin prick tests, to evaluate their potential in managing allergic reactions.

At a glance

Study Focus
Clinical trials on Betula Verrucosa Pollen (birch pollen) for allergic rhinitis and rhinoconjunctivitis
Treatment Types
Subcutaneous immunotherapy, skin prick tests, mannan-conjugated birch pollen allergoids
Patient Population
Adolescents and adults (12-65 years) with confirmed birch pollen allergies
Primary Outcomes
Symptom reduction, medication use decrease, quality of life improvement
Secondary Outcomes
Immunological changes, safety profile, effects on asthma (if applicable)
Study Designs
Randomized, double-blind, placebo-controlled trials
Treatment Duration
Typically one year, with assessment during birch pollen season
Key Measurements
TCRS, TNSS, RMS, immunoglobulin levels, lung function tests

What is Betula Verrucosa Pollen?

Betula Verrucosa Pollen, also known as Betula Pendula Pollen, is a substance derived from the pollen of birch trees. Birch trees are common in many parts of the world, particularly in temperate regions. The pollen from these trees is a frequent cause of allergies, especially during the spring season when trees release their pollen into the air.

Medical Uses

While birch pollen is often associated with causing allergies, it is also used in medical treatments, particularly in the field of allergy therapy. The primary medical uses of Betula Verrucosa Pollen include:

  • Allergy Diagnosis: It is used in skin prick tests to diagnose birch pollen allergies.
  • Immunotherapy: Betula Verrucosa Pollen is used in the treatment of birch pollen-induced allergic conditions, such as allergic rhinitis (hay fever) and allergic rhinoconjunctivitis (affecting both nose and eyes).

Administration

Betula Verrucosa Pollen is administered in different ways depending on its use:

  • Skin Prick Test: For diagnostic purposes, it is applied as a solution for skin-prick test.
  • Subcutaneous Immunotherapy (SCIT): For treatment purposes, it may be administered via subcutaneous injection.

Clinical Trials

Betula Verrucosa Pollen is currently being studied in clinical trials to further understand its effectiveness in treating allergies. Some ongoing studies include:

  • A trial investigating mannan-conjugated birch pollen allergoids for treating birch pollen-induced allergic rhinitis or rhinoconjunctivitis in adolescents and adults.
  • Studies examining its use in combination with other tree pollens for allergy treatment.

Potential Benefits

The potential benefits of Betula Verrucosa Pollen in allergy treatment include:

  • Reduction in allergy symptoms during birch pollen season
  • Decreased need for allergy medications
  • Improved quality of life for individuals with birch pollen allergies
  • Potential long-term modification of the allergic response

Side Effects and Precautions

While Betula Verrucosa Pollen is used to treat allergies, it can also cause allergic reactions, especially in sensitive individuals. Potential side effects may include:

  • Local reactions at the injection site (for SCIT)
  • Itching, redness, or swelling
  • In rare cases, more severe allergic reactions

It's important to note that Betula Verrucosa Pollen treatments should only be administered under the supervision of a healthcare professional, typically an allergist. Patients with certain conditions, such as severe asthma or other serious health issues, may not be suitable candidates for this treatment.

Conclusion

Betula Verrucosa Pollen, while a common cause of allergies, also serves as a valuable tool in allergy diagnosis and treatment. Through its use in skin prick tests and immunotherapy, it helps healthcare providers manage birch pollen allergies more effectively. Ongoing clinical trials continue to explore its potential benefits and optimal use in allergy treatment. As with any medical treatment, it's crucial to consult with a healthcare professional to determine if Betula Verrucosa Pollen-based treatments are appropriate for your specific situation.

Questions people often ask

Conditions where Betula Verrucosa Pollen is being studied

Each condition opens its own overview and trial list

Trials with Betula Verrucosa Pollen

Recruiting trials first

See all 2 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.